Summary

AVP-825 is a product containing a low-dose powder form of sumatriptan that can be delivered intranasally to treat migraines. It is better tolerated than higher doses of oral sumatriptan and has a faster onset of action. A pooled analysis of 2 studies confirmed that AVP-825 confers rapid headache relief sustained over 48 hours.